Cargando…
Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series
BACKGROUND: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease severity may vary according to immune system status. The aim of this case series is to investigate different presentation of COVID-19 in immunocompromised patients. METHODS: this is a single centre c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987579/ https://www.ncbi.nlm.nih.gov/pubmed/33777690 http://dx.doi.org/10.1016/j.rmcr.2021.101397 |
_version_ | 1783668641739309056 |
---|---|
author | Simioli, Francesca Martino, Maria Annunziata, Anna Carannante, Novella Fiorentino, Giuseppe |
author_facet | Simioli, Francesca Martino, Maria Annunziata, Anna Carannante, Novella Fiorentino, Giuseppe |
author_sort | Simioli, Francesca |
collection | PubMed |
description | BACKGROUND: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease severity may vary according to immune system status. The aim of this case series is to investigate different presentation of COVID-19 in immunocompromised patients. METHODS: this is a single centre case series about 17 immunocompromised patients admitted to our respiratory department during the recent COVID-19 pandemic. White blood cell count, C reactive protein, interleukin 6, lymphocytic subpopulation count (CD4(+), CD8(+), CD20(+)) and immunoglobulin count (IgG, IgM, IgA) were measured at hospitalization. RESULTS: the most common causes of immunosuppression observed in our severe COVID-19 population are hematological malignancies, immunosuppressant drugs for transplant, primary immunodeficiency and inflammatory bowel disease. Onset symptoms were fever (88%), cough (53%), dyspnoea (24%), asthenia (35%), anosmia and/or ageusia (17%), expectoration (12%). Compared to benign conditions, patients with malignancies show a lower lymphocytic count (490 vs 1100 cells/uL) and higher interleukin 6 (33 vs 13 pg/mL). CONCLUSIONS: immunocompromised patients are at risk of adverse outcome from COVID-19. Hematological malignancies and anti-CD20 therapies induce a high risk. Primary immunodeficiency and classical immunosuppressant such as calcineurin inhibitors and antimetabolites share an intermediate risk. |
format | Online Article Text |
id | pubmed-7987579 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-79875792021-03-24 Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series Simioli, Francesca Martino, Maria Annunziata, Anna Carannante, Novella Fiorentino, Giuseppe Respir Med Case Rep Case Report BACKGROUND: COVID-19 is a potentially critical infectious disease. Inflammatory response and disease severity may vary according to immune system status. The aim of this case series is to investigate different presentation of COVID-19 in immunocompromised patients. METHODS: this is a single centre case series about 17 immunocompromised patients admitted to our respiratory department during the recent COVID-19 pandemic. White blood cell count, C reactive protein, interleukin 6, lymphocytic subpopulation count (CD4(+), CD8(+), CD20(+)) and immunoglobulin count (IgG, IgM, IgA) were measured at hospitalization. RESULTS: the most common causes of immunosuppression observed in our severe COVID-19 population are hematological malignancies, immunosuppressant drugs for transplant, primary immunodeficiency and inflammatory bowel disease. Onset symptoms were fever (88%), cough (53%), dyspnoea (24%), asthenia (35%), anosmia and/or ageusia (17%), expectoration (12%). Compared to benign conditions, patients with malignancies show a lower lymphocytic count (490 vs 1100 cells/uL) and higher interleukin 6 (33 vs 13 pg/mL). CONCLUSIONS: immunocompromised patients are at risk of adverse outcome from COVID-19. Hematological malignancies and anti-CD20 therapies induce a high risk. Primary immunodeficiency and classical immunosuppressant such as calcineurin inhibitors and antimetabolites share an intermediate risk. Elsevier 2021-03-24 /pmc/articles/PMC7987579/ /pubmed/33777690 http://dx.doi.org/10.1016/j.rmcr.2021.101397 Text en © 2021 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Simioli, Francesca Martino, Maria Annunziata, Anna Carannante, Novella Fiorentino, Giuseppe Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title | Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title_full | Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title_fullStr | Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title_full_unstemmed | Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title_short | Therapeutic approach for severe COVID-19 and immunocompromised patients. A case series |
title_sort | therapeutic approach for severe covid-19 and immunocompromised patients. a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987579/ https://www.ncbi.nlm.nih.gov/pubmed/33777690 http://dx.doi.org/10.1016/j.rmcr.2021.101397 |
work_keys_str_mv | AT simiolifrancesca therapeuticapproachforseverecovid19andimmunocompromisedpatientsacaseseries AT martinomaria therapeuticapproachforseverecovid19andimmunocompromisedpatientsacaseseries AT annunziataanna therapeuticapproachforseverecovid19andimmunocompromisedpatientsacaseseries AT carannantenovella therapeuticapproachforseverecovid19andimmunocompromisedpatientsacaseseries AT fiorentinogiuseppe therapeuticapproachforseverecovid19andimmunocompromisedpatientsacaseseries |